newsfilter
← Latest News
GlobeNewswire·

Adagio Announces David Hering Named Permanent Chief Executive Officer and Director

WALTHAM, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc. (NASDAQ:ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases, annou